Sign in
4

Changes in Ownership

Oncotelic Therapeutics, Inc. Filed Acc 0001493152-21-017105

Director acquired 3,291,720 shares (conversion)

From the SEC's structured data for this filing

Trades in this filing

KING STEVEN W · Director

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2021-03-31 Conversion : show line 1 in the form +3,291,720 3,330,647 I

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2021-03-31 Conversion : show line 2 in the form Series A Convertible Preferred Stock −3,292 0 I
2021-07-08 Grant or award : show line 3 in the form Stock Options +357,412 357,412 D
Loading xslF345X03/ownership.xml…